Achaogen competitorsClear all
Achaogen's top competitors include Protalex.
 Achaogen Achaogen is a clinical-stage biopharmaceutical company that discovers and develops drugs to treat multi-drug resistant (MDR), gram-negative infections. |  Protalex Protalex is a clinical-stage biopharmaceutical company focused on the development of a class of drugs for treating autoimmune and inflammatory diseases. | |
Founding Date | Founding Date 2004 | Founding Date 1999 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations South San Francisco, US HQ | Locations Florham Park, US HQ |
Employees | Employees N/A | Employees 233% decrease |
Valuation ($) | Valuation ($) 1.6 m | Valuation ($) 615.2 k |
Twitter followers | Twitter followers 551 | Twitter followers 239 |
Employee Rating | Employee Rating 3.7 | Employee Rating N/A |
Financial | ||
Revenue (est.) | Revenue (est.) $8.7m (FY, 2018) | Revenue (est.) N/A |
Net income | Net income ($186.5m) (FY, 2018) | Net income ($5m) (FY, 2018) |
For sources of this data, please see the company profile
View company profiles
Protalex
HQ
Florham Park, US
Employees
2↓ 33% decrease
Protalex is a clinical-stage biopharmaceutical company focused on the development of a class of drugs for treating autoimmune and inflammatory diseases.
View company